|
Advair Poses Generic Hurdle
Wall Street Journal With a key patent on its top-selling asthma drug Advair expiring next year, GlaxoSmithKline PLC should be bracing for a steep decline in … |
View full post on asthma – Google News
Breathe Well Live Well